Radcliffe Cardiology

🌟Prof Alta Schutte PhD FESC ISHF FRSSAf explains why screening for AF and hypertension together is a no-brainer in this insightful session. 🔓✅Access free 👉 https://ow.ly/4LLT50UvOPy #EPeeps #CardioEd #AFib #AFibscreening #AFibawareness #StrokePrevention

🌟ICR³ (Journal Impact Factor™ 2.5) continues to push boundaries through impactful research, analyses and review articles. 📄Share your research with ICR³! Submit your manuscript and reach a global community of cardiovascular professionals. Start here 👉 https://ow.ly/qAAH50Uv2TV 🫀Learn more about ICR³ 👉 https://ow.ly/jBUx50Uv2TX #ICR3Journal #CardiologyResearch #CardioEd

🫀#AHA24 Thoraxcenter Wrap-up 📊🌟Prof Nicolas Van Mieghem and Dr Joost Daemen review key trials from this year's conference! Watch here 👉 https://ow.ly/M3zG50UwoJr 🔎Trials covered: ✅ CLEAR-SYNERGY ✅ SELECT-CABG ✅ YELLOW III & 4 more trials! #AHA2024 #CardioEd

🌟Join Dr Marta Kałużna-Oleksy and distinguished faculty Dr Mirvat Alasnag, Dr Shrilla Banerjee and Dr Michał Hawranek as they share cutting-edge strategies for ischemic heart disease management. Watch Now 👉 https://ow.ly/YQJf50Uw1rU 💡Based on highlights from the 2024 Prevention and Intervention meeting, topics discussed include #SCAD, #MINOCA and holistic management approaches. #CardioEd

#EPeeps: Learn Prof Andrea Sarkozy’s approach to post-ablation #AF Management ⚡️ 📺Women As One #CLIMB2024 presents Part 6 of its #AF Ablation series 👉 https://ow.ly/WjvB50Uw181 👉#PFA as a safer alternative to radiofrequency ablation 👉Deep-dive into post-ablation management strategies 👉Key take-aways from the 2024 #ESC guidelines on AF Management Stay tuned for more #EP content #CardioEd #WIC

🔍 What is the impact of the PEERLESS outcomes for Pulmonary Embolism management? Explore the latest insights in the PE hub 👉 https://ow.ly/pjOP50Uv6iz 🎥 Watch Dr Jay Giri discuss how this trial is paving the future of PE management – touching on the trial design, endpoints, patient population and its significant impact on decision-making. #PulmonaryEmbolism #PEERLESSStudy

🌟 Advancing the Management of Sudden Cardiac Death Risk in Post-MI Patients 🌟 At #NVVC 2024, Prof Cornelis Allaart and Prof Christian Meyer shared critical insights into the latest strategies for managing SCD risk in patients after acute MI: ✅ Early risk: The first 30–90 days post-MI are critical for patients with reduced LVEF ✅ Proactive protection: WCDs safeguard patients during this high-risk phase ✅ Smarter strategies: By prioritising GDMT, we’re seeing more patients recover LVEF, reducing unnecessary ICD implants Structured screenings and advanced therapies are helping us balance short-term safety with long-term outcomes. 💡This is how cardiology is saving lives and improving patient care! 💙👇 https://ow.ly/br5t50Uv3sJ https://ow.ly/eNma50Uv3sK #HeartFailure #Cardiology #PostMI

📊 From the PEERLESS RCT Trial data, Dr Stefan Stortecky highlights that the primary endpoint was met, with a significant win ratio of 5.01 favouring large-bore mechanical thrombectomy versus catheter-directed thrombolysis in the treatment of intermediate risk pulmonary embolism. 🥼 Discover how these findings fit into the latest developments in pulmonary embolism (PE) management in this insightful video series 👉 https://ow.ly/cW8L50Uu0KY This programme is supported by an unrestricted educational grant from Inari Medical. #PulmonaryEmbolism #InterventionalCardiology #PEManagement

🫀Submit your papers to #JAPSCJournal 👉 https://ow.ly/u90550Uv0wX 🔓All articles are gold open access and freely available to all. Learn More 👉 https://ow.ly/E4Wz50Uv0wY

Season’s Greetings from all at Radcliffe 🎄✨ Thank you for your continuous support this year. Wishing you a joyful festive season and a New Year filled with new opportunities and happiness! Here's to 2025 – another year of sharing medical knowledge and helping to advance patient care ♥️